Beginning Jan. 1, 2021, Bioventus’ Durolane, Gelsyn-3 and Supartz FX will be included among the four preferred knee osteoarthritis treatment options on the formulary for CVS Caremark members.
Durolane is a single-injection hyaluronic acid-based joint-fluid treatment for patients. Gelsyn-3 is a hyaluronic acid-based joint-fluid treatment requiring three injections, and Supartz is a five-injection hyaluronic acid-based joint-fluid treatment.
More articles on surgery centers:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.